| Are patents signals for the IPO market? An EU–US comparison for the software industry D Useche Research Policy 43 (8), 1299-1311, 2014 | 90 | 2014 |
| Highly skilled and well connected: Migrant inventors in cross-border M&As D Useche, E Miguelez, F Lissoni Journal of International Business Studies 51, 737-763, 2020 | 37 | 2020 |
| Orphan drug designations as valuable intangible assets for IPO investors in pharma-biotech companies P Gorry, D Useche Economic Dimensions of Personalized and Precision Medicine, 305-334, 2018 | 14 | 2018 |
| Patenting behaviour and the survival of newly listed European software firms D Useche Industry and Innovation 22 (1), 37-58, 2015 | 11 | 2015 |
| Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms D Useche, S Pommet Small Business Economics 57, 1339-1359, 2021 | 8 | 2021 |
| Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital V Butticè, D Useche Small Business Economics 59 (4), 1519-1540, 2022 | 6 | 2022 |
| Crowdfunding to overcome the liability of outsidership: Drivers of immigrant entrepreneurs’ fundraising performance V Butticè, D Useche Working Paper). Retrieved from https://conference. druid. dk/acc_papers …, 2018 | 4 | 2018 |
| Highly-skilled migrants and Cross-border M&A: Firm-level evidence D Useche, E Miguelez, F Lissoni Journal of International Business Studies 51, 737–763, 2020 | 1 | 2020 |
| Crowdfunding to overcome the liability of outsidership Drivers of immigrant entrepreneurs’ fundraising performance. Paper to be presented at DRUID19 Copenhagen Business School … V Buttice, D Useche | | 2019 |
| Conveying quality or competitive advange? Evidence for heterogeneous VCs in newly-listed technology-based firms D Useche, S Pommet | | 2018 |
| Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021 P Gorry, D Useche HAL, 2017 | | 2017 |
| Empirical Economic Analysis of Orphan Drug Innovation P Gorry, D Useche, M Zumpe HAL Post-Print, 2016 | | 2016 |
| Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies D Useche, P Gorry HAL Post-Print, 2015 | | 2015 |
| Les droits de la propriété Intellectuelle et les marchés financiers dans la stratégie des firmes du logiciel en Europe et aux Etats-Unis D Useche Bordeaux, 2014 | | 2014 |
| Call for Papers-The challenges and opportunities of high-skilled migration V Butticè, D Useche | | |
Philippe GORRYUniversity of BordeauxVerified email at u-bordeaux.fr
